AE Wealth Management LLC Sells 102,481 Shares of Merck & Co., Inc. $MRK - MarketBeat
AE Wealth Management LLC Sells 102,481 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co Company News
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - International Consortium of Investigative Journalists - ICIJ
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide International Consortium of Investigative Journalists - ICIJ
Merck & Co Inc Stock (MRK) Closed Up by 3.07% on Apr 17: What Signal Does It Send? - TradingKey
Merck & Co Inc Stock (MRK) Closed Up by 3.07% on Apr 17: What Signal Does It Send? TradingKey
Moran Wealth Management LLC Acquires 22,157 Shares of Merck & Co., Inc. $MRK - MarketBeat
Moran Wealth Management LLC Acquires 22,157 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors MarketWatch
MASTERINVEST Kapitalanlage GmbH Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
MASTERINVEST Kapitalanlage GmbH Increases Stake in Merck & Co., Inc. $MRK MarketBeat
Asset Management One Co. Ltd. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Asset Management One Co. Ltd. Grows Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Whittier Trust Co. Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Whittier Trust Co. Increases Stake in Merck & Co., Inc. $MRK MarketBeat
Whittier Trust Co. of Nevada Inc. Sells 11,310 Shares of Merck & Co., Inc. $MRK - MarketBeat
Whittier Trust Co. of Nevada Inc. Sells 11,310 Shares of Merck & Co., Inc. $MRK MarketBeat
Merit Financial Group LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Merit Financial Group LLC Increases Position in Merck & Co., Inc. $MRK MarketBeat
BCS Wealth Management Boosts Position in Merck & Co., Inc. $MRK - MarketBeat
BCS Wealth Management Boosts Position in Merck & Co., Inc. $MRK MarketBeat
Diversified Management Inc. Invests $909,000 in Merck & Co., Inc. $MRK - MarketBeat
Diversified Management Inc. Invests $909,000 in Merck & Co., Inc. $MRK MarketBeat
Greenwood Capital Associates LLC Invests $1.09 Million in Merck & Co., Inc. $MRK - MarketBeat
Greenwood Capital Associates LLC Invests $1.09 Million in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Norris Perne & French LLP MI - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Norris Perne & French LLP MI MarketBeat
Mirae Asset Global Investments Co. Ltd. Sells 178,997 Shares of Merck & Co., Inc. $MRK - MarketBeat
Mirae Asset Global Investments Co. Ltd. Sells 178,997 Shares of Merck & Co., Inc. $MRK MarketBeat
Cwm LLC Buys 61,957 Shares of Merck & Co., Inc. $MRK - MarketBeat
Cwm LLC Buys 61,957 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Consensus Rating of "Moderate Buy" from Brokerages MarketBeat
Childress Capital Advisors LLC Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Childress Capital Advisors LLC Increases Stake in Merck & Co., Inc. $MRK MarketBeat
Roof Eidam Maycock Peralta LLC Purchases New Stake in Merck & Co., Inc. $MRK - MarketBeat
Roof Eidam Maycock Peralta LLC Purchases New Stake in Merck & Co., Inc. $MRK MarketBeat
KBC Group NV Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
KBC Group NV Increases Stock Position in Merck & Co., Inc. $MRK MarketBeat
UBS Group Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
UBS Group Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price MarketBeat
Farther Finance Advisors LLC Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Farther Finance Advisors LLC Raises Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Burney Co. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Burney Co. MarketBeat
Our Q4 and full-year 2025 financial results - Merck
Our Q4 and full-year 2025 financial results Merck
Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive
Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive
The new manufacturing facilities powering our US growth - Merck
The new manufacturing facilities powering our US growth Merck
Massachusetts Financial Services Co. MA Sells 3,132,999 Shares of Merck & Co., Inc. $MRK - MarketBeat
Massachusetts Financial Services Co. MA Sells 3,132,999 Shares of Merck & Co., Inc. $MRK MarketBeat
Is Merck & Co. (NYSE:MRK) Driving Growth In The Russell 1000 Index? - Kalkine Media
Is Merck & Co. (NYSE:MRK) Driving Growth In The Russell 1000 Index? Kalkine Media
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC
U.S. Capital Wealth Advisors LLC Has $6.56 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
U.S. Capital Wealth Advisors LLC Has $6.56 Million Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Choreo LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Choreo LLC MarketBeat
5 ways we’re transforming artificial intelligence into impact - Merck
5 ways we’re transforming artificial intelligence into impact Merck
Strong Results Lifted Merck & Co (MRK) in Q4 - Yahoo Finance
Strong Results Lifted Merck & Co (MRK) in Q4 Yahoo Finance
Carnegie Investment Counsel Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Carnegie Investment Counsel Grows Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck seals $5.7bn biotech deal to boost cancer drug pipeline - Financial Times
Merck seals $5.7bn biotech deal to boost cancer drug pipeline Financial Times
Merck & Co., Inc. stock (US58933Y1055): Is Keytruda's patent cliff the real test ahead? - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Is Keytruda's patent cliff the real test ahead? AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Is Keytruda's patent cliff the real test ahead? - AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Is Keytruda's patent cliff the real test ahead? AD HOC NEWS
Ritholtz Wealth Management Purchases 10,305 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ritholtz Wealth Management Purchases 10,305 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace
Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma
Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma